This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Helixmith Co., Ltd, Viromed Co., Ltd.. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Jong Mook Kim and His Patented Gene Therapy Research.
Introduction
Jong Mook Kim is an inventor associated with Seoul, South Korea. His work includes research into gene therapy approaches for diabetic neuropathy, and he is credited with 2 patents.
Latest Patents
One of Kim’s listed patents, “Gene therapy for diabetic neuropathy using an HGF isoform,” concerns a pharmaceutical composition intended to prevent or treat diabetic neuropathy. The invention uses different isoforms of hepatocyte growth factor (HGF), or polynucleotides encoding those isoforms, as active ingredients. Its description presents the approach as a way to address diabetic neuropathy through HGF-based therapy.
Career Highlights
Kim has been associated with Helixmith Co., Ltd. and Viromed Co., Ltd. His patent work reflects a focus on therapeutic applications of gene-based technologies.
Collaborations
Jae Gyun Jeong is identified as a coworker associated with Kim’s work.
Conclusion
Jong Mook Kim’s patent portfolio highlights research into HGF-based gene therapy for diabetic neuropathy and his professional associations with biotechnology companies in South Korea.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile